C WorldWide Group’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.8M | Buy |
450,000
+50,000
| +13% | +$1.98M | 0.24% | 39 |
|
|
2025
Q1 | $12.1M | Hold |
400,000
| – | – | 0.15% | 57 |
|
|
2024
Q4 | $14M | Buy |
400,000
+100,000
| +33% | +$3.5M | 0.17% | 50 |
|
|
2024
Q3 | $12M | Hold |
300,000
| – | – | 0.12% | 63 |
|
|
2024
Q2 | $14.3M | Hold |
300,000
| – | – | 0.15% | 61 |
|
|
2024
Q1 | $13M | Hold |
300,000
| – | – | 0.15% | 60 |
|
|
2023
Q4 | $15.2M | Buy |
+300,000
| New | +$15.2M | 0.2% | 46 |
|
|
2018
Q4 | – | Sell |
-5,248
| Closed | -$271K | – | 127 |
|
|
2018
Q3 | $271K | Buy |
5,248
+765
| +17% | +$39.5K | ﹤0.01% | 124 |
|
|
2018
Q2 | $187K | Hold |
4,483
| – | – | ﹤0.01% | 124 |
|
|
2018
Q1 | $198K | Sell |
4,483
-151
| -3% | -$6.67K | ﹤0.01% | 119 |
|
|
2017
Q4 | $233K | Sell |
4,634
-651
| -12% | -$32.7K | ﹤0.01% | 114 |
|
|
2017
Q3 | $268K | Sell |
5,285
-250
| -5% | -$12.7K | ﹤0.01% | 119 |
|
|
2017
Q2 | $282K | Sell |
5,535
-467
| -8% | -$23.8K | ﹤0.01% | 117 |
|
|
2017
Q1 | $241K | Buy |
6,002
+2
| +0% | +$80 | ﹤0.01% | 117 |
|
|
2016
Q4 | $287K | Sell |
6,000
-31,100
| -84% | -$1.49M | 0.01% | 110 |
|
|
2016
Q3 | $1.36M | Buy |
37,100
+2,100
| +6% | +$76.9K | 0.02% | 103 |
|
|
2016
Q2 | $815K | Sell |
35,000
-19,500
| -36% | -$454K | 0.02% | 99 |
|
|
2016
Q1 | $2.21M | Sell |
54,500
-21,560
| -28% | -$873K | 0.04% | 67 |
|
|
2015
Q4 | $4.71M | Sell |
76,060
-15,000
| -16% | -$929K | 0.08% | 54 |
|
|
2015
Q3 | $3.68M | Buy |
91,060
+360
| +0.4% | +$14.6K | 0.06% | 64 |
|
|
2015
Q2 | $5.22M | Sell |
90,700
-7,400
| -8% | -$426K | 0.07% | 57 |
|
|
2015
Q1 | $6.25M | Sell |
98,100
-28,080
| -22% | -$1.79M | 0.09% | 50 |
|
|
2014
Q4 | $7.79M | Sell |
126,180
-61,320
| -33% | -$3.79M | 0.11% | 44 |
|
|
2014
Q3 | $7.35M | Buy |
+187,500
| New | +$7.35M | 0.11% | 47 |
|